Illumina, Inc. (ILMN) Cash Flow Statement

The erratic OCF/NI ratio is largely attributable to the GRAIL divestiture and related charges, which distorted net income in 2024. In Q2 2026, the ratio near 1.0 suggests a normalization, but the wide quarterly swings warrant caution in extrapolating earnings quality. Investors should monitor whether the ratio stabilizes above 1.0 as the core business matures.

The sharp recovery in FCF reflects both operational improvement and the elimination of GRAIL-related cash burn. However, the Q2 2026 margin contraction suggests some quarter-to-quarter variability, possibly due to working capital timing or increased investment. The trajectory appears positive, but sustainability depends on maintaining revenue growth and disciplined capex.

The moderate capex intensity suggests that Illumina's growth is driven more by consumables and software than by heavy manufacturing investment. This supports the razor-and-blade model, where the installed base generates recurring revenue without proportional capital outlays. However, the NovaSeq X transition may require incremental investment, which could temporarily raise capex.

The small working capital swings indicate that Illumina's cash conversion cycle is stable, with no significant buildup in inventory or receivables. This is consistent with a consumables-driven model where orders are relatively predictable. However, the lack of large positive contributions means FCF is largely dependent on operating earnings rather than working capital release.

The aggressive buyback activity suggests management is returning cash to shareholders, possibly to offset dilution from stock-based compensation. The $415M acquisition outflow in Q2 2026 is notable and may be tied to the GRAIL divestiture or other strategic moves. Investors should assess whether buybacks are value-accretive given the stock's valuation and the need for investment in innovation.

The cumulative OCF exceeding net income by over $1.3B is largely due to non-cash charges like depreciation, amortization, and impairment losses, particularly from the GRAIL write-down. This indicates that the underlying cash-generating ability of the core business is stronger than reported earnings suggest. However, the gap may narrow as one-time charges fade, so investors should focus on normalized earnings power.